Search results
Results from the WOW.Com Content Network
Though secondary osteoporosis is a separate category when it comes to osteoporosis diagnosis, it can still be a contributing factor to primary osteoporosis. Secondary osteoporosis can be present in pre- and post-menopausal women and in men and have found to be factors contributing to osteoporosis in both sexes (50-80% of men and 30% of post ...
The US National Osteoporosis Foundation recommends pharmacologic treatment for patients with hip or spine fracture thought to be related to osteoporosis, those with BMD 2.5 SD or more below the young normal mean (T-score -2.5 or below), and those with BMD between 1 and 2.5 SD below normal mean whose 10-year risk, using FRAX, for hip fracture is ...
Some women lose up to 25% of bone mass in the first 10 years after menopause. Have a small, thin body (weigh less than 127 pounds) Have a family history of osteoporosis. Are Mexican-American or white.
As of 2014, The National Osteoporosis Foundation (NOF) recommends pharmaceutical treatment for osteopenic postmenopausal women and men over 50 with FRAX hip fracture probability of >3% or FRAX MOF probability >20%. [40] As of 2016, the American Association of Clinical Endocrinologists and the American College of Endocrinology agree. [41]
Metabolic bone disease is an abnormality of bones caused by a broad spectrum of disorders. Most commonly these disorders are caused by deficiencies of minerals such as calcium, phosphorus, magnesium or vitamin D leading to dramatic clinical disorders that are commonly reversible once the underlying defect has been treated.
There are several kinds of kyphosis (ICD-10 codes are provided): Postural kyphosis (M40.0), the most common type, normally attributed to slouching, can occur in both the old [7] and the young. In the young, it can be called "slouching" and is reversible by correcting muscular imbalances.
Bone resorption rates are much higher in post-menopausal older women due to estrogen deficiency related with menopause. [7] Common treatments include drugs that increase bone mineral density. Bisphosphonates , RANKL inhibitors , SERMs— selective oestrogen receptor modulators , hormone replacement therapy and calcitonin are some of the common ...
A variety of conditions can lead to hypoestrogenism: menopause is the most common. [5] Primary ovarian insufficiency (premature menopause) due to varying causes, such as radiation therapy, chemotherapy, or a spontaneous manifestation, can also lead to low estrogen and infertility. [17]